Independent Advisor Alliance Buys 10,779 Shares of Oracle Corporation $ORCL

Independent Advisor Alliance raised its position in shares of Oracle Corporation (NYSE:ORCL) by 17.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 73,486 shares of the enterprise software provider’s stock after purchasing an additional 10,779 shares during the period. Oracle accounts for approximately 0.5% of Independent Advisor Alliance’s portfolio, making the stock its 26th largest holding. Independent Advisor Alliance’s holdings in Oracle were worth $20,667,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in ORCL. Frank Rimerman Advisors LLC lifted its position in shares of Oracle by 24.7% during the 3rd quarter. Frank Rimerman Advisors LLC now owns 23,349 shares of the enterprise software provider’s stock valued at $6,567,000 after buying an additional 4,625 shares during the last quarter. Centric Wealth Management lifted its holdings in Oracle by 0.6% during the third quarter. Centric Wealth Management now owns 17,771 shares of the enterprise software provider’s stock valued at $4,667,000 after purchasing an additional 102 shares during the last quarter. Everhart Financial Group Inc. boosted its position in Oracle by 7.5% during the third quarter. Everhart Financial Group Inc. now owns 13,469 shares of the enterprise software provider’s stock worth $3,788,000 after purchasing an additional 934 shares during the period. Lingohr Asset Management GmbH increased its stake in shares of Oracle by 616.3% in the third quarter. Lingohr Asset Management GmbH now owns 21,855 shares of the enterprise software provider’s stock worth $6,136,000 after purchasing an additional 18,804 shares in the last quarter. Finally, Werba Rubin Papier Wealth Management raised its position in shares of Oracle by 3.6% in the third quarter. Werba Rubin Papier Wealth Management now owns 4,512 shares of the enterprise software provider’s stock valued at $1,269,000 after purchasing an additional 155 shares during the period. 42.44% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ORCL. JPMorgan Chase & Co. reduced their price objective on shares of Oracle from $270.00 to $230.00 and set a “neutral” rating for the company in a research note on Thursday, December 11th. KeyCorp decreased their price objective on Oracle from $350.00 to $300.00 and set an “overweight” rating on the stock in a research note on Thursday, December 11th. DA Davidson cut their target price on Oracle from $200.00 to $180.00 and set a “neutral” rating for the company in a research note on Thursday, December 11th. Guggenheim reaffirmed a “buy” rating and set a $400.00 target price on shares of Oracle in a report on Thursday, December 11th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $400.00 price target on shares of Oracle in a report on Monday, January 5th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Oracle presently has a consensus rating of “Moderate Buy” and an average target price of $300.46.

Trending Headlines about Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Analyst bullish call — An analyst dubbed Oracle a “decade stock” that could more than double over time, arguing current weakness (debt and AI worries) may create a buying opportunity for long-term investors. Oracle is a “Decade Stock,” Could More Than Double, Says Analyst
• Positive Sentiment: New product launch in healthcare — Oracle unveiled the Life Sciences AI Data Platform, expanding its generative-AI offerings into pharma/clinical data (129M+ de-identified records), which could drive enterprise revenue and higher-margin services. Oracle Life Sciences AI Data Platform
• Positive Sentiment: Customer win in hospitality — IHG approved Oracle OPERA Cloud as a property-management provider across multiple regions, a commercial endorsement that supports recurring cloud bookings and cross-sell opportunities. Oracle Approved by IHG Hotels & Resorts
• Positive Sentiment: Shareholder returns track record — A Forbes piece highlights Oracle’s large capital return program (~$158B returned), a structural positive for investors who value buybacks and dividends during pullbacks. How Oracle Stock Returned $158B To Shareholders
• Neutral Sentiment: Options-service commentary — Schaeffer’s Weekend Trader highlighted ORCL as a “popular cloud stock pick for 2026” and provided a specific bearish options trade to subscribers — indicates active derivatives strategies around the name. Popular Cloud Stock Pick for 2026 Option Bears
• Neutral Sentiment: Trending/market context — Coverage notes ORCL is trending amid a broader tech sell-off; some press attributes intraday moves more to sector rotation than company-specific guidance. Oracle Stock Is Trending Thursday: What’s Going On?
• Negative Sentiment: Investor lawsuits and bondholder investigations — Rosen Law (senior notes), Pomerantz, and Girard Sharp have issued notices/investigations tied to Oracle’s 2024-2025 offerings and the 2025 AI buildout deal, increasing legal risk and potential financial exposure. ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Oracle Corporation Investors
• Negative Sentiment: AI-related sell-off driving sharp declines — Multiple outlets report the stock has tumbled more than 50% from its peak as investors punish OpenAI exposure, AI buildout costs and leverage concerns; this narrative is the primary immediate driver of price weakness. Oracle Stock Drops by More Than Half Amid AI Concerns
• Negative Sentiment: Market analysis of the decline — Reports from The Motley Fool and Zacks attribute recent slump to broad AI sell-off and investor unease over debt/OpenAI ties, reinforcing downside momentum. Why Oracle Stock Slumped on Thursday

Oracle Stock Down 2.6%

Shares of NYSE:ORCL opened at $164.69 on Friday. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $345.72. The firm has a fifty day moving average of $194.12 and a 200 day moving average of $237.44. The firm has a market capitalization of $473.17 billion, a PE ratio of 30.96, a price-to-earnings-growth ratio of 1.48 and a beta of 1.65. The company has a debt-to-equity ratio of 3.28, a quick ratio of 0.91 and a current ratio of 0.91.

Oracle (NYSE:ORCL) last issued its quarterly earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The firm had revenue of $16.06 billion during the quarter, compared to analyst estimates of $16.19 billion. During the same quarter in the previous year, the company posted $1.47 earnings per share. The company’s revenue was up 14.2% compared to the same quarter last year. As a group, research analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 23rd. Investors of record on Friday, January 9th were given a $0.50 dividend. The ex-dividend date was Friday, January 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.2%. Oracle’s payout ratio is presently 37.59%.

Insider Transactions at Oracle

In other news, Director Naomi O. Seligman sold 2,223 shares of the company’s stock in a transaction on Tuesday, December 23rd. The shares were sold at an average price of $196.61, for a total value of $437,064.03. Following the completion of the sale, the director owned 25,596 shares of the company’s stock, valued at approximately $5,032,429.56. This represents a 7.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Clayton M. Magouyrk sold 10,000 shares of Oracle stock in a transaction on Friday, December 19th. The stock was sold at an average price of $192.52, for a total transaction of $1,925,200.00. Following the completion of the transaction, the chief executive officer owned 144,030 shares in the company, valued at approximately $27,728,655.60. The trade was a 6.49% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 62,223 shares of company stock worth $12,136,764 in the last three months. Corporate insiders own 40.90% of the company’s stock.

About Oracle

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.